Holen Sie sich die Stockscreener-App
2.61
1.88%
-0.05
Handel nachbörslich:
2.55
-0.06
-2.30%
Finanzdaten der Aerovate Therapeutics Inc-Aktie (AVTE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
11.57%
24.62
|
22.07 | 21.37 | 20.34 | 17.64 |
| Operating Income/Loss |
11.57%
-24.62
|
-22.07 | -21.37 | -20.34 | -17.64 |
| Income/Loss From Continuing Operations Before Tax |
13.90%
-23.19
|
-20.36 | -19.56 | -19.02 | -16.52 |
| Income/Loss From Continuing Operations After Tax |
13.58%
-23.19
|
-20.41 | -19.56 | -19.02 | -16.52 |
|
Net Income/Loss
|
13.58%
-23.19
|
-20.41 | -19.56 | -19.02 | -16.52 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
5,949%
27.80
|
0.4595 | 27.64 | 25.17 | 24.78 |
| Diluted Average Shares |
5,949%
27.80
|
0.4595 | 27.64 | 25.17 | 24.78 |
| Basic Earnings Per Share |
12.16%
-0.83
|
-0.74 | -0.71 | -0.76 | -0.67 |
| Diluted Earnings Per Share |
12.16%
-0.83
|
-0.74 | -0.71 | -0.76 | -0.67 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):